Recombinant Candida glabrata Protein SIP5 (SIP5)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder

Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.

Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.

Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.

Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.

Tag type is determined during production. Please specify your required tag type for preferential development.

Synonyms
SIP5; CAGL0I00836g; Protein SIP5
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-469
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)
Target Names
SIP5
Target Protein Sequence
MGNVPAKLDQ DASSYTGRST YTDSSSASGV GAFRGAGGTM DETRARGRRT SSLVGNILNG PTSSRNDPTG EVSKKQLSAA KKRGTKEREL LKEENAKKLV IKYNETVDGG YLAPHGCYSL DKMDYDSDIV RKLIIERKLA PFYIPLQDFD DSWTKDEVKK IVDALPLHAP FNEHVEEYED VPVGDLNEPH FDYLIDKKLS KKEQKKMHAL IFKARLYRKR LRWQESENNA YLEEKLQNRD NDIPKNSFLP NDDLKYDLYA QGSECPICFL YLPMPLNYSK CCQQPICSEC FVQIKRSEPH FPHDEVDPSQ PQKDENEKDP NLLISEPANC PYCATPNFSI TYTPPTGRKV GIGGQAPNLY KPLGTAGNAP PTYTVSSDDI RPDWETKLNK ERVRLARRSA NATAIHVSNR LIGPQRTGSF ANEDSPGVAG STDSRSAGVA NSTLEELEKQ MIDEAIRLSL QDEKRKAKR
Uniprot No.

Target Background

Function

May negatively regulate the SNF1 kinase.

Database Links
Protein Families
SIP5 family
Subcellular Location
Cytoplasm.

Q&A

What is Candida glabrata and why is it a significant research organism?

Candida glabrata is the second most commonly isolated fungal pathogen after C. albicans, together causing approximately three-quarters of all systemic candidiasis cases. C. glabrata can cause infections ranging from mild vulvovaginal candidiasis to severe, drug-resistant invasive infections affecting the bloodstream (candidemia) with potential dissemination to vital organs. Bloodstream infections caused by Candida species are associated with mortality rates of 30-60%, making C. glabrata a clinically relevant research organism . Understanding C. glabrata proteins is crucial for developing new therapeutic strategies against this pathogen.

What are the common approaches for expressing recombinant proteins from C. glabrata?

Recombinant protein expression from C. glabrata typically employs several methodological approaches:

  • Heterologous expression systems: Using Saccharomyces cerevisiae as an expression host due to its genetic similarity to C. glabrata

  • Native expression: Expressing the protein in C. glabrata itself using vectors with appropriate selection markers

  • Promoter selection: Utilizing inducible promoters such as the copper-induced MTI promoter for controlled expression

  • Vector design: Employing plasmids containing S. cerevisiae CEN/ARS elements, which have been shown to function in C. glabrata

For optimal expression, researchers typically clone the target gene into vectors like pGREG576, which can be modified to include appropriate promoters and tags for protein visualization and purification .

What genetic tools are available for manipulating C. glabrata genes for recombinant expression?

Several genetic tools and approaches are available for C. glabrata gene manipulation:

  • Selectable markers: Common markers include URA3, LEU2 (as seen in the L5U1 strain - cgura3Δ0; cgleu2Δ0)

  • Homologous recombination: For targeted gene deletion or modification, exemplified in studies with CgDTR1 and other genes

  • Promoter replacement: Substituting native promoters with controllable ones like the copper-inducible MTI promoter

  • Fusion proteins: Creating GFP fusion constructs for localization studies and expression verification

  • CRISPR-Cas9 systems: Adapted for C. glabrata to enable precise genome editing

These tools allow for precise manipulation of target genes, facilitating the study of protein function through recombinant expression approaches.

How does protein localization affect the function of recombinant C. glabrata proteins, and what methods can verify proper localization?

Protein localization is critical for proper function, particularly for membrane or secreted proteins in C. glabrata. For instance, transporters like CgFlr1 and CgFlr2 must correctly localize to the plasma membrane to confer drug resistance . Similarly, the acetate transporter CgDtr1 needs proper membrane localization to impact virulence .

Methods to verify proper localization include:

  • Fluorescence microscopy: Using GFP fusion proteins to directly visualize localization in living cells. This approach has been successfully employed for CgFlr1 and CgFlr2 proteins using excitation and emission wavelengths of 395 and 509 nm, respectively

  • Subcellular fractionation: Separating cellular components (membrane, cytosol, nucleus) followed by Western blotting

  • Proteomic analysis: Using techniques like iTRAQ-based approaches to identify proteins in membrane fractions

  • Functional complementation: Testing whether the recombinant protein can restore function in deletion mutants

Importantly, expression conditions must be optimized to ensure proper folding and localization. For membrane proteins like transporters, induction protocols (e.g., using 50 μM CuSO₄ for the MTI promoter) have been established to achieve correct localization .

What role do recombinant C. glabrata proteins play in studying drug resistance mechanisms?

Recombinant C. glabrata proteins have been instrumental in understanding drug resistance mechanisms, particularly through the following approaches:

  • Overexpression systems: Expressing transporters like CgFlr1 and CgFlr2 to assess their role in drug efflux and resistance to antifungals like flucytosine

  • Deletion-complementation studies: Deleting genes and then complementing with recombinant expression to confirm specific roles in resistance

  • Protein modification: Creating mutated versions of proteins to identify specific domains involved in drug interactions

  • Interaction studies: Identifying protein partners that contribute to resistance mechanisms

Research has shown that proteins like CgFlr1 function as drug:H⁺ antiporters conferring flucytosine resistance, while CgFlr2 provides resistance to both flucytosine and azole drugs . These findings highlight how recombinant protein studies can reveal mechanisms underlying clinical antifungal resistance.

How can genetic diversity within C. glabrata populations impact recombinant protein expression and function studies?

The genetic diversity within C. glabrata populations significantly impacts recombinant protein studies through several mechanisms:

  • Sequence variation: Genome analysis of 68 clinical isolates from Scotland plus 83 global isolates revealed substantial genetic diversity that may affect protein sequence and function

  • Mitochondrial genome diversity: Particularly diverse mitochondrial genomes with reduced conserved sequence were identified in nonreference ST15 isolates, which could affect proteins involved in mitochondrial function

  • Strain-dependent expression levels: Different C. glabrata strains show varying levels of virulence (e.g., L5U1 appears less virulent than KUE100), which may reflect differences in protein expression patterns

  • Microevolution during infection: Evidence of microevolution was found in clinical isolates, indicating that proteins may adapt during the course of infection

When working with recombinant proteins, researchers should consider:

  • Using sequencing to confirm the gene sequence in their particular strain

  • Testing expression and function in multiple genetic backgrounds

  • Considering how sequence variations might impact protein structure and function

  • Acknowledging that findings from one strain may not be universally applicable

What are the optimal methods for purifying recombinant C. glabrata membrane proteins?

Purifying membrane proteins from C. glabrata requires specialized approaches:

  • Cell disruption: Mechanical disruption using glass beads or enzymatic methods with cell wall-degrading enzymes

  • Membrane isolation: Differential centrifugation to separate membrane fractions

  • Solubilization: Using appropriate detergents to solubilize membrane proteins while maintaining native structure

  • Affinity chromatography: Employing tags (His, FLAG, etc.) for selective purification

  • Size exclusion: Further purification based on protein size

For membrane proteins like transporters (CgFlr1, CgFlr2, CgDtr1), specific considerations include:

  • Detergent selection: Different membrane proteins require specific detergents for optimal solubilization

  • Buffer optimization: Maintaining proper pH and ionic strength to preserve protein stability

  • Reconstitution: For functional studies, reconstitution into liposomes or nanodiscs

  • Stabilization: Addition of specific lipids or cholesterol analogs that maintain protein stability

Researchers often verify purification success through Western blotting, mass spectrometry, and functional assays specific to the protein's activity .

What techniques are most effective for characterizing protein-protein interactions involving C. glabrata proteins?

Several techniques have proven effective for characterizing protein-protein interactions in C. glabrata:

  • Co-immunoprecipitation (Co-IP): Using tagged recombinant proteins to pull down interaction partners

  • Yeast two-hybrid (Y2H): Particularly useful for screening potential interactors

  • Proximity-based labeling: BioID or APEX2 approaches to identify proteins in close proximity in vivo

  • Mass spectrometry-based proteomics: Techniques like iTRAQ labeling have been successfully employed to identify protein complexes in C. glabrata

  • Fluorescence microscopy: Using split-GFP or FRET approaches to visualize interactions in living cells

For membrane proteins, such as transporters or cell surface proteins, specialized approaches may include:

  • Membrane-based Y2H systems: Modified for membrane protein interactions

  • Liposome reconstitution: Reconstituting potential partners in artificial membranes

  • Crosslinking approaches: Chemical crosslinking followed by mass spectrometry

These methods have revealed important interactions, such as those in stress response pathways and drug resistance mechanisms in C. glabrata.

How can researchers effectively study the role of recombinant C. glabrata proteins in virulence?

Studying recombinant C. glabrata proteins in virulence contexts requires multiple complementary approaches:

  • In vivo infection models: Using models such as Galleria mellonella larvae, which have been successfully employed to assess the virulence contribution of proteins like CgDtr1

  • Survival analysis: Monitoring host survival rates using Kaplan-Meier survival curves after infection with wild-type vs. deletion mutants

  • Complementation studies: Reintroducing the gene of interest via expression plasmids to restore virulence phenotypes

  • Stress response assays: Testing protein contributions to stress tolerance (oxidative stress, pH stress) relevant to host-pathogen interactions

  • Host-pathogen interaction studies: Examining interactions with host cells, particularly phagocytes

For example, research with CgDtr1 demonstrated that:

  • Deletion of CgDTR1 decreased C. glabrata's ability to kill G. mellonella larvae by 30%

  • Overexpression of CgDTR1 led to a 50% decrease in G. mellonella survival rate

  • The protein conferred resistance to oxidative and acetic acid stress, enhancing survival against host immune defenses

These methodologies provide comprehensive insights into how specific proteins contribute to virulence mechanisms.

How does genetic exchange and recombination in C. glabrata impact protein function studies?

Genetic exchange and recombination in C. glabrata represent important mechanisms generating diversity that researchers must consider when studying protein function:

  • Evidence of recombination: Genome analysis of clinical isolates has revealed evidence of genetic exchange and recombination as major mechanisms generating diversity in C. glabrata populations

  • Impact on protein encoding: Recombination events can lead to mosaic genes, potentially creating proteins with altered functions or domain structures

  • Horizontal gene transfer: While less common in fungi than bacteria, evidence suggests some genes may be acquired through horizontal transfer

  • Mating pathway repurposing: Despite predominantly asexual reproduction, C. glabrata has repurposed mating signaling pathways for other functions, as seen with the Yhi1 protein regulated by the mating MAPK signaling pathway

When conducting protein function studies, researchers should:

  • Sequence verify genes from multiple strains to identify variant forms

  • Consider how recombination events might create functional variation

  • Evaluate whether the protein of interest shows evidence of positive selection

  • Test protein function across different genetic backgrounds

Understanding these evolutionary processes provides context for interpreting functional studies of recombinant C. glabrata proteins.

What roles do C. glabrata proteins play in inter-species interactions during infection?

C. glabrata proteins mediate important inter-species interactions that influence pathogenesis:

  • Mixed-species infections: During mixed-species invasive candidiasis, C. albicans presence is nearly essential for host colonization by C. glabrata

  • Secreted factors: C. glabrata secretes proteins that can influence other Candida species, such as Yhi1, which induces hyphal growth in C. albicans—an essential process for host tissue invasion

  • Specificity of interactions: The Yhi1-based interaction is specific to C. glabrata and C. albicans, not extending to other common Candida species

  • Functional motifs: Structure-function analyses have revealed a novel functional pentapeptide motif (AXVXH) required for Yhi1 function

These inter-species interactions have significant research implications:

  • Potential for developing biomarkers for mixed infections

  • Templates for novel antifungal peptides

  • Understanding how proteins from one species can modulate virulence in another

For researchers studying recombinant C. glabrata proteins, considering these inter-species effects is crucial for comprehensive functional characterization.

How do mitochondrial genome variations in C. glabrata affect protein function studies?

Mitochondrial genome variations in C. glabrata have significant implications for protein function studies:

  • Reduced conservation: The C. glabrata mitochondrial genome shows particularly diverse sequences with reduced conserved regions in nonreference ST15 isolates

  • Variable protein-encoding genes: Conserved protein-encoding genes are reduced in numerous isolates, potentially affecting mitochondrial protein expression and function

  • Impact on cellular processes: Mitochondrial variations can affect energy metabolism, stress responses, and virulence traits

  • Nuclear-mitochondrial interactions: Variations in mitochondrial genomes may necessitate compensatory changes in nuclear-encoded proteins that interact with mitochondrial components

When studying recombinant C. glabrata proteins, especially those with mitochondrial functions or interactions, researchers should:

  • Consider the mitochondrial background of their strain

  • Assess whether mitochondrial variations might affect their protein of interest

  • Evaluate nuclear-mitochondrial protein interactions

  • Test function in multiple strains with different mitochondrial backgrounds

These considerations are particularly important for proteins involved in energy metabolism, oxidative stress responses, and certain drug resistance mechanisms.

What proteomics approaches are most informative for studying C. glabrata proteins in different conditions?

Several proteomics approaches have proven highly informative for studying C. glabrata proteins:

  • iTRAQ-based quantitative proteomics: Successfully employed to analyze membrane proteome changes in response to 5-flucytosine, identifying 32 proteins with significant expression changes

  • Sample preparation methods: Specific protocols for C. glabrata include:

    • Protein digestion with Lys-C (3h at 37°C) followed by trypsin (overnight at 37°C)

    • Macro-spin desalt with C18 spin columns

    • Dissolution in 500 mM TEAB

  • Search parameters: Optimal parameters include:

    • Peaklist generating software: ProteinPilot 4.5 and Mascot

    • Search engine: Paragon Search Engine (ProteinPilot 4.2)

  • Subcellular fractionation: Specific isolation of membrane fractions for targeted proteomics

These approaches allow researchers to:

  • Identify proteins that respond to specific conditions (e.g., drug exposure)

  • Quantify relative protein abundance changes

  • Discover proteins under specific regulatory control (e.g., 50% of 5-FC responsive proteins are under CgPdr1 control)

  • Group proteins into functional clusters for systems-level analysis

For comprehensive characterization of recombinant C. glabrata proteins, combining these proteomics approaches with targeted functional assays provides the most robust insights.

How can researchers effectively measure and characterize the transport activity of recombinant C. glabrata membrane proteins?

Characterizing transport activity of C. glabrata membrane proteins requires specialized approaches:

  • Heterologous expression systems: Expression in S. cerevisiae deletion mutants lacking similar transporters provides a clean background for functional assays

  • Fluorescent substrate transport: Using fluorescent dyes that are transported substrates to monitor real-time activity

  • Radioactive substrate uptake/efflux: Measuring movement of radiolabeled substrates across membranes

  • pH-sensitive indicators: For transporters coupled to proton movement (like drug:H⁺ antiporters CgFlr1 and CgFlr2)

  • Electrophysiological methods: For transporters that generate electrical currents

  • Reconstituted systems: Purified proteins reconstituted into liposomes or proteoliposomes

For the acetate transporter CgDtr1, researchers demonstrated its function as a plasma membrane acetic acid exporter by:

  • Showing its role in conferring resistance to acetic acid stress

  • Demonstrating its ability to relieve acetic acid stress within phagocytic cells

  • Correlating transport activity with virulence in the G. mellonella model

These functional assays are essential for understanding the physiological roles of membrane transporters and their contributions to drug resistance and virulence.

What are the most effective strategies for studying the regulation of C. glabrata protein expression?

Understanding the regulation of C. glabrata protein expression requires multi-faceted approaches:

  • Promoter analysis: Identifying regulatory elements through reporter gene fusions

  • Transcription factor binding: ChIP-seq or similar approaches to identify transcription factor binding sites

  • Expression profiling: RNA-seq under various conditions to identify co-regulated genes

  • Regulatory mutants: Testing expression in strains with deletions of known regulators

  • Post-transcriptional regulation: Analyzing mRNA stability, translation efficiency, and protein degradation

Research has revealed important regulatory mechanisms for C. glabrata proteins:

  • CgPdr1 transcription factor controls 50% of proteins that respond to 5-flucytosine

  • The mating MAPK signaling pathway regulates Yhi1 expression despite C. glabrata's predominantly asexual reproduction

  • The pheromone transporter CgSte6 is involved in Yhi1 efflux, demonstrating repurposing of mating pathway components

These findings illustrate how C. glabrata has evolved unique regulatory mechanisms that may differ from model yeasts like S. cerevisiae, necessitating direct study in the pathogen itself.

How can systems biology approaches enhance our understanding of C. glabrata protein functions?

Systems biology approaches offer powerful tools for comprehensively understanding C. glabrata protein functions:

  • Network analysis: Constructing protein-protein interaction networks to place individual proteins in broader cellular contexts

  • Metabolic modeling: Creating genome-scale metabolic models to predict the effects of protein perturbations

  • Multi-omics integration: Combining proteomics, transcriptomics, and metabolomics data for holistic understanding

  • Comparative systems approaches: Comparing protein networks across different Candida species to identify conserved and species-specific modules

For C. glabrata proteins, systems approaches have revealed:

  • Functional protein clusters associated with cell wall assembly, lipid metabolism, amino acid/nucleotide metabolism, translation machinery, mitochondrial function, glucose metabolism, and multidrug resistance

  • How individual proteins like transporters fit into broader stress response networks

  • Evolutionary repurposing of pathways, such as the mating pathway components for virulence functions

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.